methamphetamine has been researched along with u 0126 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bai, Y; Buch, S; Chao, J; Chen, L; Duan, M; Lv, X; Wu, X; Yao, H; Zhang, Y; Zhu, X | 1 |
Chao, J; Hu, G; Yao, H; Zhang, X; Zhang, Y; Zhu, T | 1 |
Dang, DK; Jang, CG; Jeong, JH; Kim, HC; Ledent, C; Mai, AT; Nabeshima, T; Nah, SY; Onaivi, ES; Shin, EJ; Yamamoto, T | 1 |
3 other study(ies) available for methamphetamine and u 0126
Article | Year |
---|---|
Involvement of sigma-1 receptor in astrocyte activation induced by methamphetamine via up-regulation of its own expression.
Topics: Animals; Animals, Newborn; Astrocytes; Butadienes; Cells, Cultured; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ethylenediamines; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitriles; Rats; Rats, Sprague-Dawley; Receptors, sigma; Sigma-1 Receptor; Signal Transduction; Up-Regulation | 2015 |
Role of high-mobility group box 1 in methamphetamine-induced activation and migration of astrocytes.
Topics: Animals; Astrocytes; Butadienes; Cell Line, Transformed; Cell Movement; Dopamine Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ethylenediamines; Gene Expression Regulation; Glial Fibrillary Acidic Protein; HMGB1 Protein; Humans; Methamphetamine; Mitogen-Activated Protein Kinase Kinases; NF-kappa B; Nitriles; Rats; RNA, Small Interfering; Signal Transduction; Time Factors | 2015 |
Genetic or pharmacological depletion of cannabinoid CB1 receptor protects against dopaminergic neurotoxicity induced by methamphetamine in mice.
Topics: Animals; Apoptosis; Butadienes; Cells, Cultured; Corpus Striatum; Dopamine; Extracellular Signal-Regulated MAP Kinases; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurotoxicity Syndromes; Nitriles; Oxidative Stress; Piperidines; Protein Kinase C-delta; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Dopamine D2; Rimonabant; Sulpiride | 2017 |